225 related articles for article (PubMed ID: 35351824)
1. TET2-mediated epigenetic reprogramming of breast cancer cells impairs lysosome biogenesis.
Laurent A; Madigou T; Bizot M; Turpin M; Palierne G; Mahé E; Guimard S; Métivier R; Avner S; Le Péron C; Salbert G
Life Sci Alliance; 2022 Jul; 5(7):. PubMed ID: 35351824
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
[TBL] [Abstract][Full Text] [Related]
3. TET2 coactivates gene expression through demethylation of enhancers.
Wang L; Ozark PA; Smith ER; Zhao Z; Marshall SA; Rendleman EJ; Piunti A; Ryan C; Whelan AL; Helmin KA; Morgan MA; Zou L; Singer BD; Shilatifard A
Sci Adv; 2018 Nov; 4(11):eaau6986. PubMed ID: 30417100
[TBL] [Abstract][Full Text] [Related]
4. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2.
Doege CA; Inoue K; Yamashita T; Rhee DB; Travis S; Fujita R; Guarnieri P; Bhagat G; Vanti WB; Shih A; Levine RL; Nik S; Chen EI; Abeliovich A
Nature; 2012 Aug; 488(7413):652-5. PubMed ID: 22902501
[TBL] [Abstract][Full Text] [Related]
5. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
Poole CJ; Lodh A; Choi JH; van Riggelen J
Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
[TBL] [Abstract][Full Text] [Related]
6. Tumour suppressor TET2 safeguards enhancers from aberrant DNA methylation and epigenetic reprogramming in ERα-positive breast cancer cells.
Lyu R; Zhu X; Shen Y; Xiong L; Liu L; Liu H; Wu F; Argueta C; Tan L
Epigenetics; 2022 Oct; 17(10):1180-1194. PubMed ID: 34689714
[TBL] [Abstract][Full Text] [Related]
7. DNA methylcytosine dioxygenase ten-eleven translocation 2 enhances lipopolysaccharide-induced cytokine expression in human dental pulp cells by regulating MyD88 hydroxymethylation.
Wang X; Feng Z; Li Q; Yi B; Xu Q
Cell Tissue Res; 2018 Aug; 373(2):477-485. PubMed ID: 29654353
[TBL] [Abstract][Full Text] [Related]
8. SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response.
Chen LL; Lin HP; Zhou WJ; He CX; Zhang ZY; Cheng ZL; Song JB; Liu P; Chen XY; Xia YK; Chen XF; Sun RQ; Zhang JY; Sun YP; Song L; Liu BJ; Du RK; Ding C; Lan F; Huang SL; Zhou F; Liu S; Xiong Y; Ye D; Guan KL
Cell Rep; 2018 Nov; 25(6):1485-1500.e4. PubMed ID: 30404004
[TBL] [Abstract][Full Text] [Related]
9. Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX.
Ko M; An J; Bandukwala HS; Chavez L; Aijö T; Pastor WA; Segal MF; Li H; Koh KP; Lähdesmäki H; Hogan PG; Aravind L; Rao A
Nature; 2013 May; 497(7447):122-6. PubMed ID: 23563267
[TBL] [Abstract][Full Text] [Related]
10. TET2 directs mammary luminal cell differentiation and endocrine response.
Kim MR; Wu MJ; Zhang Y; Yang JY; Chang CJ
Nat Commun; 2020 Sep; 11(1):4642. PubMed ID: 32934200
[TBL] [Abstract][Full Text] [Related]
11. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6.
Zhang Q; Zhao K; Shen Q; Han Y; Gu Y; Li X; Zhao D; Liu Y; Wang C; Zhang X; Su X; Liu J; Ge W; Levine RL; Li N; Cao X
Nature; 2015 Sep; 525(7569):389-393. PubMed ID: 26287468
[TBL] [Abstract][Full Text] [Related]
12. Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency.
Wille CK; Li Y; Rui L; Johannsen EC; Kenney SC
J Virol; 2017 Mar; 91(5):. PubMed ID: 28003489
[TBL] [Abstract][Full Text] [Related]
13. [TET proteins and epigenetic modifications in cancers].
Ciesielski P; Jóźwiak P; Krześlak A
Postepy Hig Med Dosw (Online); 2015 Dec; 69():1371-83. PubMed ID: 26671928
[TBL] [Abstract][Full Text] [Related]
14. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS.
Deplus R; Delatte B; Schwinn MK; Defrance M; Méndez J; Murphy N; Dawson MA; Volkmar M; Putmans P; Calonne E; Shih AH; Levine RL; Bernard O; Mercher T; Solary E; Urh M; Daniels DL; Fuks F
EMBO J; 2013 Mar; 32(5):645-55. PubMed ID: 23353889
[TBL] [Abstract][Full Text] [Related]
15. TET2 promotes IL-1β expression in J774.1 cell through TLR4/MAPK signaling pathway with demethylation of TAB2 promoter.
Liang Y; Zeng J; Luo B; Li W; He Y; Zhao W; Hu N; Jiang N; Luo Y; Xian Y; Liu J; Zheng X
Mol Immunol; 2020 Oct; 126():136-142. PubMed ID: 32823238
[TBL] [Abstract][Full Text] [Related]
16. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes.
Gu TP; Guo F; Yang H; Wu HP; Xu GF; Liu W; Xie ZG; Shi L; He X; Jin SG; Iqbal K; Shi YG; Deng Z; Szabó PE; Pfeifer GP; Li J; Xu GL
Nature; 2011 Sep; 477(7366):606-10. PubMed ID: 21892189
[TBL] [Abstract][Full Text] [Related]
17. Ten-eleven translocation 2 demethylates the
Li X; Wu C; Shen Y; Wang K; Tang L; Zhou M; Yang M; Pan T; Liu X; Xu W
J Biol Chem; 2018 Jun; 293(26):10059-10070. PubMed ID: 29773648
[TBL] [Abstract][Full Text] [Related]
18. TET2: A Novel Epigenetic Regulator and Potential Intervention Target for Atherosclerosis.
Liu Y; Peng W; Qu K; Lin X; Zeng Z; Chen J; Wei D; Wang Z
DNA Cell Biol; 2018 Jun; 37(6):517-523. PubMed ID: 29653065
[TBL] [Abstract][Full Text] [Related]
19. Association of high 5-hydroxymethylcytosine levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients.
Lagos C; Carvajal P; Castro I; Jara D; González S; Aguilera S; Barrera MJ; Quest AFG; Bahamondes V; Molina C; Urzúa U; Hermoso MA; Leyton C; González MJ
Clin Immunol; 2018 Nov; 196():85-96. PubMed ID: 29894742
[TBL] [Abstract][Full Text] [Related]
20. 5mC profiling characterized TET2 as an anti-adipogenic demethylase.
Hou Y; Zhang Z; Wang Y; Gao T; Liu X; Tang T; Du Q
Gene; 2020 Apr; 733():144265. PubMed ID: 31805318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]